Cansino Biologics Inc (688185) — Free Cash Flow Generation Index

Latest as of September 2025: -0.45x

Cansino Biologics Inc (688185) has a Free Cash Flow Generation Index of -0.45x as of September 2025. Free cash flow of CN¥-13.70 Million represents 0% of operating cash flow (CN¥30.53 Million). Explore Cansino Biologics Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

-0.45x

Free Cash Flow / Operating CF

Free Cash Flow

CN¥-13.70 Million

CNY

Operating Cash Flow

CN¥30.53 Million

CNY

Capital Expenditures

CN¥44.23 Million

CNY

Cansino Biologics Inc Free Cash Flow Generation Index (2021–2025)

Historical FCF Generation Index trend for Cansino Biologics Inc across 2 annual periods. For the full cash flow conversion analysis, see Cansino Biologics Inc (688185) cash conversion ratio.

Annual Free Cash Flow Generation for Cansino Biologics Inc (2021–2025)

Year-by-year Free Cash Flow Generation Index for Cansino Biologics Inc. Check how aggressively does Cansino Biologics Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Year	FCG Index	Free Cash Flow (CNY)	Operating CF	Capital Expenditures	YoY Change
2025	-2.13x	CN¥-166.04 Million	CN¥77.86 Million	CN¥243.90 Million	▼ -629.5%
2021	0.40x	CN¥811.42 Million	CN¥2.01 Billion	CN¥1.20 Billion	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).